Diana Luca

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 449 citations · Full text

Antineutrophil cytoplasmic antibodies in ulcerative colitis

Francesco Giuseppe De Rosa, Antonella Afeltra, D. Caccavo et al. · 1995 · 242 citations

Inflammation, Rheumatology, Autoimmune Disease +6

Burosumab for the Treatment of Tumor-Induced Osteomalacia

Suzanne M. Jan de Beur, Paul D. Miller, Thomas J. Weber et al. · Journal of Bone and Mineral Research · 2020 · 167 citations · Full text

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis

Gaik W. Tew, Jason A. Hackney, Deena L. Gibbons et al. · Gastroenterology · 2015 · 153 citations · Full text

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

Paul Rutgeerts, Richard N. Fedorak, Daan W. Hommes et al. · Gut · 2012 · 150 citations · Full text